Literature DB >> 16937161

Artificial neural network based model for cardiovascular risk stratification in hypertension.

Gangmin Ning1, Jie Su, Yingqi Li, Xiaoying Wang, Chenghong Li, Weimin Yan, Xiaoxiang Zheng.   

Abstract

This study was to develop an objective method to stratify cardiovascular risk in hypertension. Stratification for cardiovascular risk is crucial in deciding treatment strategy for hypertension but has yielded undesirable results in clinic due to its low accuracy which is caused by physicians' subjective experience and the uncertainty of patients' statements. Our model proposed herein overcomes these disadvantages by applying artificial neural network based on a classic back propagation net. The model input is derived from the clinical investigation. The target output is the stratification level of total cardiovascular risk, which is learned from the guidelines of hypertension treatment. Study in 348 normotensive and hypertensive subjects showed that the results of model stratification are consistent with the standard stratification suggested by hypertension guidelines in 81.61% cases. The results confirm the accuracy of the model and demonstrate its ability in risk evaluation for hypertension.

Entities:  

Mesh:

Year:  2006        PMID: 16937161     DOI: 10.1007/s11517-006-0028-2

Source DB:  PubMed          Journal:  Med Biol Eng Comput        ISSN: 0140-0118            Impact factor:   2.602


  15 in total

Review 1.  Fifty years of Framingham Study contributions to understanding hypertension.

Authors:  W B Kannel
Journal:  J Hum Hypertens       Date:  2000-02       Impact factor: 3.012

2.  1999 World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension. Guidelines Subcommittee.

Authors: 
Journal:  J Hypertens       Date:  1999-02       Impact factor: 4.844

3.  [A cross-sectional study on knowledge and the ability of hypertension treatment among physicians in district and community hospitals].

Authors:  Wen-hua Wang; Dong Zhao; Zhe-chun Zeng; Yan-na Jia; Ying Liu; Xiu-ping Zhu; Zhi-xiang Wang
Journal:  Zhonghua Liu Xing Bing Xue Za Zhi       Date:  2003-12

4.  Use of an artificial neural network to predict Graves' disease outcome within 2 years of drug withdrawal.

Authors:  E Orunesu; M Bagnasco; C Salmaso; V Altrinetti; D Bernasconi; P Del Monte; G Pesce; M Marugo; G S Mela
Journal:  Eur J Clin Invest       Date:  2004-03       Impact factor: 4.686

5.  Use of neural networks in predicting the risk of coronary artery disease.

Authors:  P Lapuerta; S P Azen; L LaBree
Journal:  Comput Biomed Res       Date:  1995-02

6.  Relation between serum uric acid and risk of cardiovascular disease in essential hypertension. The PIUMA study.

Authors:  P Verdecchia; G Schillaci; G Reboldi; F Santeusanio; C Porcellati; P Brunetti
Journal:  Hypertension       Date:  2000-12       Impact factor: 10.190

7.  Neural network classification of pediatric posterior fossa tumors using clinical and imaging data.

Authors:  Shaad Bidiwala; Thomas Pittman
Journal:  Pediatr Neurosurg       Date:  2004 Jan-Feb       Impact factor: 1.162

8.  2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension.

Authors: 
Journal:  J Hypertens       Date:  2003-06       Impact factor: 4.844

Review 9.  Risk stratification for the prevention of cardiovascular complications of hypertension.

Authors:  Xavier Girerd; Philippe Giral
Journal:  Curr Med Res Opin       Date:  2004-07       Impact factor: 2.580

10.  Improved cardiovascular risk stratification by a simple ECG index in hypertension.

Authors:  Paolo Verdecchia; Fabio Angeli; Gianpaolo Reboldi; Erberto Carluccio; Guglielmo Benemio; Roberto Gattobigio; Claudia Borgioni; Maurizio Bentivoglio; Carlo Porcellati; Giuseppe Ambrosio
Journal:  Am J Hypertens       Date:  2003-08       Impact factor: 2.689

View more
  1 in total

1.  Application of gene expression programming and neural networks to predict adverse events of radical hysterectomy in cervical cancer patients.

Authors:  Maciej Kusy; Bogdan Obrzut; Jacek Kluska
Journal:  Med Biol Eng Comput       Date:  2013-10-18       Impact factor: 2.602

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.